↓ Skip to main content

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Overview of attention for article published in Journal of Clinical Oncology, February 1999
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy
2 policy sources
patent
1 patent
guideline
1 clinical guideline source

Readers on

mendeley
105 Mendeley